WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Michelle Yost Hale
Partner
Antitrust and Competition
Washington, D.C.
mhale@wsgr.com

D202-973-8836

Download vCard
Open PDF
  • Regulatory Strategist

    Michelle’s former government experience shapes her approach to crafting effective strategies for clients, including advocating for strategic transactions and managing civil investigations.

  • Robinson-Patman Act Expertise

    Michelle brings extensive expertise in navigating the complexities of the Robinson-Patman Act, advising clients on pricing and distribution practices to ensure compliance and mitigate the risk of violations.

Michelle Hale focuses on complex, government-facing antitrust matters. Michelle regularly represents companies before the Federal Trade Commission (FTC) and the U.S. Department of Justice in conduct and merger investigations, including specializing in matters involving investigations into potential Robinson-Patman Act violations. This experience informs her ability to provide effective antitrust counseling on a wide range of business conduct, including joint ventures, collaborations, and pricing and distribution, among others. She also has extensive experience navigating through the complexities of the U.S. HSR and multi-jurisdictional filing processes.

Prior to joining the firm, Michelle served as a lead attorney in the Mergers IV division of the FTC, where she led matters related to the healthcare, supermarket, and retail industries. During her time at the FTC, Michelle also served as counsel to the director of the Bureau of Competition, where she advised two Bureau of Competition directors on a wide range of antitrust issues. She has significant litigation experience and served as an integral member of the FTC's trial team in the FTC's successful challenges to ProMedica Health System's acquisition of St. Luke's Hospital.

Experience

Michelle Hale focuses on complex, government-facing antitrust matters. Michelle regularly represents companies before the Federal Trade Commission (FTC) and the U.S. Department of Justice in conduct and merger investigations, including specializing in matters involving investigations into potential Robinson-Patman Act violations. This experience informs her ability to provide effective antitrust counseling on a wide range of business conduct, including joint ventures, collaborations, and pricing and distribution, among others. She also has extensive experience navigating through the complexities of the U.S. HSR and multi-jurisdictional filing processes.

Prior to joining the firm, Michelle served as a lead attorney in the Mergers IV division of the FTC, where she led matters related to the healthcare, supermarket, and retail industries. During her time at the FTC, Michelle also served as counsel to the director of the Bureau of Competition, where she advised two Bureau of Competition directors on a wide range of antitrust issues. She has significant litigation experience and served as an integral member of the FTC's trial team in the FTC's successful challenges to ProMedica Health System's acquisition of St. Luke's Hospital.

Education
  • J.D., Howard University School of Law, 2007Member, Civil Rights Clinic; Technical Editor, Howard Scroll: The Social Justice Law Review
  • B.A., Communications, Virginia Tech, 2001Concentration in Public Relations, Minors in Black Studies and Spanish
Honors
  • Recognized in the D.C. Antitrust category in the 2025-2026 editions of Chambers USA
  • Selected for inclusion in the 2023-2026 editions of Lawdragon's "500 Leading Litigators in America" and the 2025-2026 editions of its "500 Leading Global Antitrust & Competition Lawyers" guide
  • Honored by the FTC in 2010 with the Stephen Nye Award—the highest award given to a junior attorney at the FTC
  • Received an award for meritorious service in 2010 for her contributions to the FTC's investigation into Google's acquisition of AdMob
  • Honored with the FTC's Janet D. Steiger Award in 2008 for her contributions to the Inova/Prince William litigation and again in 2012 for her contributions in several hospital merger litigations
Admissions
  • Bar of the District of Columbia
  • State Bar of New York
Credentials
Education
  • J.D., Howard University School of Law, 2007Member, Civil Rights Clinic; Technical Editor, Howard Scroll: The Social Justice Law Review
  • B.A., Communications, Virginia Tech, 2001Concentration in Public Relations, Minors in Black Studies and Spanish
Honors
  • Recognized in the D.C. Antitrust category in the 2025-2026 editions of Chambers USA
  • Selected for inclusion in the 2023-2026 editions of Lawdragon's "500 Leading Litigators in America" and the 2025-2026 editions of its "500 Leading Global Antitrust & Competition Lawyers" guide
  • Honored by the FTC in 2010 with the Stephen Nye Award—the highest award given to a junior attorney at the FTC
  • Received an award for meritorious service in 2010 for her contributions to the FTC's investigation into Google's acquisition of AdMob
  • Honored with the FTC's Janet D. Steiger Award in 2008 for her contributions to the Inova/Prince William litigation and again in 2012 for her contributions in several hospital merger litigations
Admissions
  • Bar of the District of Columbia
  • State Bar of New York

Select Representations

Transactions

  • Represented Walmart as a third party in the federal and state litigations to enjoin the Kroger/Albertsons merger
  • Represented Run:ai Labs in its sale to Nvidia
  • Represented ForgeRock in its $2.3 billion acquisition by Thoma Bravo
  • Represented Bungie in its sale to Sony
  • Represented Vertos Medical, Inc. in its acquisition by Stryker
  • Represented Genesis Medtech in its carve out transaction to JC Edwards
  • Represented Mobile Health on its acquisition by H.I.G. Growth
  • Represented SilkRoad Medical in its sale to Boston Scientific
  • Represented Foresight Diagnostics in its strategic partnership with Allogene Therapeutics
  • Represented Amphastar in its acquisition of BAQSIMI from Eli Lilly
  • Represented Caption Health in its sale to GE HealthCare
  • Represented PacBio in its attempted merger with Illumina
  • Represented Price Chopper Supermarkets in its merger with Tops Friendly Markets
  • Advised Northrop Grumman Corporation on its successful $3.4 billion sale of Federal IT and mission support services businesses to Peraton, a Veritas portfolio company
  • Represented Vivint Solar in connection with its acquisition by SunRun, a transaction that combined two of the leading solar financing companies in the world, in an investigation by the Department of Justice
  • Advised Nintex in its successful merger with K2
  • Represented Southeastern Grocers, Inc., in its sale of grocery stores and a distribution center to Ahold Delhaize, in a Second Request investigation conducted by the FTC; the matter was cleared without conditions
  • Represented Brocade in connection with its sale to Broadcom
  • Represented iControl in connection with its sale to Alarm.com, in a Second Request investigation by the Federal Trade Commission

Conduct Investigations

  • Represented a Fortune 500 company in conjunction with an investigation into compliance with a FTC order
  • Represented a Fortune 50 company as a market participant in several Robinson-Patman Act investigations
  • Represented a significant trade association in ongoing antitrust and compliance counseling related to ongoing investigations
  • Represented a leading security and compliance company in the Department of Justice’s investigation into the Section 8 interlocking directorates issue
  • Represented numerous non-public investigations into retail and grocery transactions
Matters

Select Representations

Transactions

  • Represented Walmart as a third party in the federal and state litigations to enjoin the Kroger/Albertsons merger
  • Represented Run:ai Labs in its sale to Nvidia
  • Represented ForgeRock in its $2.3 billion acquisition by Thoma Bravo
  • Represented Bungie in its sale to Sony
  • Represented Vertos Medical, Inc. in its acquisition by Stryker
  • Represented Genesis Medtech in its carve out transaction to JC Edwards
  • Represented Mobile Health on its acquisition by H.I.G. Growth
  • Represented SilkRoad Medical in its sale to Boston Scientific
  • Represented Foresight Diagnostics in its strategic partnership with Allogene Therapeutics
  • Represented Amphastar in its acquisition of BAQSIMI from Eli Lilly
  • Represented Caption Health in its sale to GE HealthCare
  • Represented PacBio in its attempted merger with Illumina
  • Represented Price Chopper Supermarkets in its merger with Tops Friendly Markets
  • Advised Northrop Grumman Corporation on its successful $3.4 billion sale of Federal IT and mission support services businesses to Peraton, a Veritas portfolio company
  • Represented Vivint Solar in connection with its acquisition by SunRun, a transaction that combined two of the leading solar financing companies in the world, in an investigation by the Department of Justice
  • Advised Nintex in its successful merger with K2
  • Represented Southeastern Grocers, Inc., in its sale of grocery stores and a distribution center to Ahold Delhaize, in a Second Request investigation conducted by the FTC; the matter was cleared without conditions
  • Represented Brocade in connection with its sale to Broadcom
  • Represented iControl in connection with its sale to Alarm.com, in a Second Request investigation by the Federal Trade Commission

Conduct Investigations

  • Represented a Fortune 500 company in conjunction with an investigation into compliance with a FTC order
  • Represented a Fortune 50 company as a market participant in several Robinson-Patman Act investigations
  • Represented a significant trade association in ongoing antitrust and compliance counseling related to ongoing investigations
  • Represented a leading security and compliance company in the Department of Justice’s investigation into the Section 8 interlocking directorates issue
  • Represented numerous non-public investigations into retail and grocery transactions

Select Publications

  • Co-author, “The Trump FTC Takes New Action Against Non-Competes, While Abandoning Defense of the Biden-Era Non-Compete Clause Rule,” Wilson Sonsini Alert, September 12, 2025

  • Co-author, “DOJ Carries Through on Revitalization of Merger Remedies,” Wilson Sonsini Alert, June 16, 2025

  • Co-author, “’Beat Mist’ Campaign Draws Scrutiny from DOJ in Merger Challenge,” Wilson Sonsini Alert, February 5, 2025

  • Co-author, “Whither Antitrust Enforcement Under Trump 2.0?” Wilson Sonsini Alert, November 15, 2024

  • Co-author, “Old-Fashioned Approach Still Wins It for the FTC in Luxury Goods Merger Challenge,” Wilson Sonsini Alert, October 30, 2024

  • Co-author with A. Welch-Alleyne, "Anti-Steering Provisions in Healthcare Contracts: Anticompetitive or Acceptable?" American Bar Association, July 18, 2022
  • Co-author with S. Sher, J. Ferris, and J. Miller, "Distribution Merger Challenges at the FTC," Wilson Sonsini Goodrich & Rosati article, March 2021
  • Co-author with S. Sher and R. Crauthers, "United States: Digital Platforms," Americas Antitrust Review 2020, Global Competition Review Insight, 2019

Select Speaking Engagements

  • "Antitrust on Tap: Mergers, Market, Enforcement and the Future of Competition in the Alcohol Industry," National Conference of State Liquor Administrators 2025 Annual Conference, Lahaina, HI, June 2025
  • “The Current State of Competition Law (Federal and State),” Competition Law Seminar, Salt Lake City, UT, April 2025
  • "Antitrust Update for the ABA Corporate Counseling Committee," ABA webinar, June 30, 2022
Insights

Select Publications

  • Co-author, “The Trump FTC Takes New Action Against Non-Competes, While Abandoning Defense of the Biden-Era Non-Compete Clause Rule,” Wilson Sonsini Alert, September 12, 2025

  • Co-author, “DOJ Carries Through on Revitalization of Merger Remedies,” Wilson Sonsini Alert, June 16, 2025

  • Co-author, “’Beat Mist’ Campaign Draws Scrutiny from DOJ in Merger Challenge,” Wilson Sonsini Alert, February 5, 2025

  • Co-author, “Whither Antitrust Enforcement Under Trump 2.0?” Wilson Sonsini Alert, November 15, 2024

  • Co-author, “Old-Fashioned Approach Still Wins It for the FTC in Luxury Goods Merger Challenge,” Wilson Sonsini Alert, October 30, 2024

  • Co-author with A. Welch-Alleyne, "Anti-Steering Provisions in Healthcare Contracts: Anticompetitive or Acceptable?" American Bar Association, July 18, 2022
  • Co-author with S. Sher, J. Ferris, and J. Miller, "Distribution Merger Challenges at the FTC," Wilson Sonsini Goodrich & Rosati article, March 2021
  • Co-author with S. Sher and R. Crauthers, "United States: Digital Platforms," Americas Antitrust Review 2020, Global Competition Review Insight, 2019

Select Speaking Engagements

  • "Antitrust on Tap: Mergers, Market, Enforcement and the Future of Competition in the Alcohol Industry," National Conference of State Liquor Administrators 2025 Annual Conference, Lahaina, HI, June 2025
  • “The Current State of Competition Law (Federal and State),” Competition Law Seminar, Salt Lake City, UT, April 2025
  • "Antitrust Update for the ABA Corporate Counseling Committee," ABA webinar, June 30, 2022
Focus Areas
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • Antitrust and Competition
  • Antitrust and Intellectual Property
  • Defense Tech
  • Third-Party Merger and Non-Merger Antitrust Representation
Recent Insights
Client Highlights
Firm Advises Denali Therapeutics on Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
On June 18, 2026, Denali Therapeutics, a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using its proprietary TransportVehicle™ platform, announced it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $195 million. Wilson Sonsini Goodrich & Rosati advised Denali on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises SewerAI on Strategic Investment
On June 2, 2026, SewerAI, a leading AI platform for sewer and underground infrastructure intelligence, announced a major strategic investment led by JMI Equity, a leading growth equity software investor based in the greater Washington, D.C., area and San Diego, with continued participation from Innovius Capital, Epic Ventures, and Bentley Systems. Wilson Sonsini Goodrich & Rosati advised SewerAI on the transaction.
Learn More
View All
Recent Events
Speaking Engagements
2026 ABA Business Law Spring Meeting
Join Wilson Sonsini partners Michelle Yost Hale and Matthew McDonald, and Of Counsel Seth Cowell, at the 2026 Business Law Spring Meeting, April 16–18 in Atlanta, Georgia.
Learn More
Affiliated Programs
GCR Live: Women in Antitrust 2025
On November 18, Wilson Sonsini partner Michelle Yost Hale participate in GCR Live: Women in Antitrust as a member of the Steering Committee. She will also moderate the panel, "Antitrust Defending the Home Front: The Impact of National Security and Geopolitical Trends on Regulation," where panelists will discuss antitrust considerations with national security issues and the defense industry.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.